[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Keratinocyte;
DOI=10.1006/jmbi.1993.1346; PubMed=8515476 [NCBI, ExPASy, EBI, Israel, Japan]
Leffers H.,
Madsen P.,
Rasmussen H.H.,
Honore B.,
Andersen A.H.,
Walbum E.,
Vandekerckhove J.,
Celis J.E.;
"Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway.";
J. Mol. Biol. 231:982-998(1993).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/414865a; PubMed=11780052 [NCBI, ExPASy, EBI, Israel, Japan]
Deloukas P.,
Matthews L.H.,
Ashurst J.L.,
Burton J.,
Gilbert J.G.R.,
Jones M.,
Stavrides G.,
Almeida J.P.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Barlow K.F.,
Bates K.N.,
Beard L.M.,
Beare D.M.,
Beasley O.P.,
Bird C.P.,
Blakey S.E.,
Bridgeman A.M.,
Brown A.J.,
Buck D.,
Burrill W.D.,
Butler A.P.,
Carder C.,
Carter N.P.,
Chapman J.C.,
Clamp M.,
Clark G.,
Clark L.N.,
Clark S.Y.,
Clee C.M.,
Clegg S.,
Cobley V.E.,
Collier R.E.,
Connor R.E.,
Corby N.R.,
Coulson A.,
Coville G.J.,
Deadman R.,
Dhami P.D.,
Dunn M.,
Ellington A.G.,
Frankland J.A.,
Fraser A.,
French L.,
Garner P.,
Grafham D.V.,
Griffiths C.,
Griffiths M.N.D.,
Gwilliam R.,
Hall R.E.,
Hammond S.,
Harley J.L.,
Heath P.D.,
Ho S.,
Holden J.L.,
Howden P.J.,
Huckle E.,
Hunt A.R.,
Hunt S.E.,
Jekosch K.,
Johnson C.M.,
Johnson D.,
Kay M.P.,
Kimberley A.M.,
King A.,
Knights A.,
Laird G.K.,
Lawlor S.,
Lehvaeslaiho M.H.,
Leversha M.A.,
Lloyd C.,
Lloyd D.M.,
Lovell J.D.,
Marsh V.L.,
Martin S.L.,
McConnachie L.J.,
McLay K.,
McMurray A.A.,
Milne S.A.,
Mistry D.,
Moore M.J.F.,
Mullikin J.C.,
Nickerson T.,
Oliver K.,
Parker A.,
Patel R.,
Pearce T.A.V.,
Peck A.I.,
Phillimore B.J.C.T.,
Prathalingam S.R.,
Plumb R.W.,
Ramsay H.,
Rice C.M.,
Ross M.T.,
Scott C.E.,
Sehra H.K.,
Shownkeen R.,
Sims S.,
Skuce C.D.,
Smith M.L.,
Soderlund C.,
Steward C.A.,
Sulston J.E.,
Swann R.M.,
Sycamore N.,
Taylor R.,
Tee L.,
Thomas D.W.,
Thorpe A.,
Tracey A.,
Tromans A.C.,
Vaudin M.,
Wall M.,
Wallis J.M.,
Whitehead S.L.,
Whittaker P.,
Willey D.L.,
Williams L.,
Williams S.A.,
Wilming L.,
Wray P.W.,
Hubbard T.,
Durbin R.M.,
Bentley D.R.,
Beck S.,
Rogers J.;
"The DNA sequence and comparative analysis of human chromosome 20.";
Nature 414:865-871(2001).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[4]
|
PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND MASS SPECTROMETRY.
TISSUE=Colon carcinoma;
Bienvenut W.V.,
Zebisch A.,
Kolch W.;
Submitted (DEC-2008) to UniProtKB.
|
[5]
|
PROTEIN SEQUENCE OF 3-20.
TISSUE=Platelet;
DOI=10.1038/nbt810; PubMed=12665801 [NCBI, ExPASy, EBI, Israel, Japan]
Gevaert K.,
Goethals M.,
Martens L.,
Van Damme J.,
Staes A.,
Thomas G.R.,
Vandekerckhove J.;
"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.";
Nat. Biotechnol. 21:566-569(2003).
|
[6]
|
INTERACTION WITH CRTC2.
DOI=10.1016/j.cell.2004.09.015; PubMed=15454081 [NCBI, ExPASy, EBI, Israel, Japan]
Screaton R.A.,
Conkright M.D.,
Katoh Y.,
Best J.L.,
Canettieri G.,
Jeffries S.,
Guzman E.,
Niessen S.,
Yates J.R. III,
Takemori H.,
Okamoto M.,
Montminy M.;
"The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.";
Cell 119:61-74(2004).
|
[7]
|
INTERACTION WITH SSH1.
DOI=10.1083/jcb.200401136; PubMed=15159416 [NCBI, ExPASy, EBI, Israel, Japan]
Nagata-Ohashi K.,
Ohta Y.,
Goto K.,
Chiba S.,
Mori R.,
Nishita M.,
Ohashi K.,
Kousaka K.,
Iwamatsu A.,
Niwa R.,
Uemura T.,
Mizuno K.;
"A pathway of neuregulin-induced activation of cofilin-phosphatase Slingshot and cofilin in lamellipodia.";
J. Cell Biol. 165:465-471(2004).
|
[8]
|
SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
DOI=10.1021/pr060363j; PubMed=17081065 [NCBI, ExPASy, EBI, Israel, Japan]
Chi A.,
Valencia J.C.,
Hu Z.-Z.,
Watabe H.,
Yamaguchi H.,
Mangini N.J.,
Huang H.,
Canfield V.A.,
Cheng K.C.,
Yang F.,
Abe R.,
Yamagishi S.,
Shabanowitz J.,
Hearing V.J.,
Wu C.,
Appella E.,
Hunt D.F.;
"Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.";
J. Proteome Res. 5:3135-3144(2006).
|
[9]
|
INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND MASS SPECTROMETRY.
DOI=10.1210/me.2007-0323; PubMed=17717073 [NCBI, ExPASy, EBI, Israel, Japan]
Liu Y.,
Ross J.F.,
Bodine P.V.N.,
Billiard J.;
"Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(beta) phosphorylation and promotes osteoblast differentiation and bone formation.";
Mol. Endocrinol. 21:3050-3061(2007).
|
[10]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[11]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, MASS SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
DOI=10.1073/pnas.0605779103; PubMed=17085597 [NCBI, ExPASy, EBI, Israel, Japan]
Yang X.,
Lee W.H.,
Sobott F.,
Papagrigoriou E.,
Robinson C.V.,
Grossmann J.G.,
Sundstroem M.,
Doyle D.A.,
Elkins J.M.;
"Structural basis for protein-protein interactions in the 14-3-3 protein family.";
Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
|
|
- FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathway. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis.
- SUBUNIT: Homodimer. Interacts with SSH1 and TORC2/CRTC2. Interacts with ABL1; the interaction results in cytoplasmic location of ABL1 and inhition of cABL-mediated apoptosis. Interacts with ROR2 (dimer); the interaction results in phosphorylation of YWHAB on tyrosine residues.
- INTERACTION:
Q9P0K1-1:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567258;
Q9P0K1-3:ADAM22; NbExp=1; IntAct=EBI-359815, EBI-1567267;
Q12802:AKAP13; NbExp=1; IntAct=EBI-359815, EBI-1373806;
O43521:BCL2L11; NbExp=1; IntAct=EBI-359815, EBI-526406;
P15056:BRAF; NbExp=1; IntAct=EBI-359815, EBI-365980;
P46527:CDKN1B; NbExp=1; IntAct=EBI-359815, EBI-519280;
Q9P2M7:CGN; NbExp=1; IntAct=EBI-359815, EBI-79537;
P68400:CSNK2A1; NbExp=1; IntAct=EBI-359815, EBI-347804;
Q7Z401:DENND4A; NbExp=1; IntAct=EBI-359815, EBI-1046479;
Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
Q96F86:EDC3; NbExp=1; IntAct=EBI-359815, EBI-997311;
Q9Y2J2:EPB41L3; NbExp=1; IntAct=EBI-359815, EBI-310986;
Q96TC7:FAM82A2; NbExp=1; IntAct=EBI-359815, EBI-1056589;
O94915:FRYL; NbExp=1; IntAct=EBI-359815, EBI-1104821;
Q9Y4H2:IRS2; NbExp=1; IntAct=EBI-359815, EBI-1049582;
Q02241:KIF23; NbExp=1; IntAct=EBI-359815, EBI-306852;
P33176:KIF5B; NbExp=1; IntAct=EBI-359815, EBI-355878;
Q07866:KLC1; NbExp=1; IntAct=EBI-359815, EBI-721019;
Q6PKG0:LARP1; NbExp=1; IntAct=EBI-359815, EBI-1052114;
P27448:MARK3; NbExp=1; IntAct=EBI-359815, EBI-707595;
Q6WCQ1:MPRIP; NbExp=1; IntAct=EBI-359815, EBI-1022605;
Q9Y2A7:NCKAP1; NbExp=1; IntAct=EBI-359815, EBI-389845;
Q9H4L5:OSBPL3; NbExp=1; IntAct=EBI-359815, EBI-1051317;
Q8TEW0:PARD3; NbExp=1; IntAct=EBI-359815, EBI-81968;
O94921:PFTK1; NbExp=5; IntAct=EBI-359815, EBI-1043945;
Q9UBF8:PI4KB; NbExp=1; IntAct=EBI-359815, EBI-1053214;
Q9UJ41:RABGEF1; NbExp=1; IntAct=EBI-359815, EBI-913954;
Q9H0H5:RACGAP1; NbExp=1; IntAct=EBI-359815, EBI-717233;
P04049:RAF1; NbExp=4; IntAct=EBI-359815, EBI-365996;
Q9P0K7:RAI14; NbExp=1; IntAct=EBI-359815, EBI-1023749;
Q5PRF9:SAMD4B; NbExp=1; IntAct=EBI-359815, EBI-1047489;
Q9Y6M7:SLC4A7; NbExp=1; IntAct=EBI-359815, EBI-1044546;
Q9UQ35:SRRM2; NbExp=1; IntAct=EBI-359815, EBI-1050142;
Q9UDY2:TJP2; NbExp=1; IntAct=EBI-359815, EBI-1042602;
P40818:USP8; NbExp=1; IntAct=EBI-359815, EBI-1050865;
- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
- ALTERNATIVE PRODUCTS:
2 named isoforms [FASTA] produced by alternative initiation.
|
| Name | Short |
| Isoform ID | P31946-2 |
| Note: Contains a N-acetylmethionine at position 1 (By similarity). |
| Features which should be applied to build the isoform sequence: VSP_018632. |
|
|
- PTM: The alpha, brain-specific form differs from the beta form in being phosphorylated (By similarity).
- PTM: Isoform Short contains a N-acetylmethionine at position 1 (By similarity).
- SIMILARITY: Belongs to the 14-3-3 family.
|